Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases-Reference-Cited by-同舟云学术

Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases

Published:2023-10 Issue: Volume:192 Page:113287
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Dohm Ammoren E.,Nakashima Justyn Y.,Kalagotla Hruday,Jiang Shirley X.,Tang Joseph D.,Bhandari Menal,Kim Youngchul^ORCID,Graham Jasmine A.,Khushalani Nikhil I.,Forsyth Peter A.,Etame Arnold B.,Liu James K.,Tran Nam D.,Vogelbaum Michael A.,Wuthrick Evan J.,Yu Hsiang-Hsuan Michael,Oliver Daniel E.,Ahmed Kamran A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. New era in the management of melanoma brain metastases;Tawbi;Am Soc Clin Oncol Educ Book/ASCO Am Soc Clin Oncol Meeting,2018

2. Melanoma central nervous system metastases: an update to approaches, challenges, and opportunities;Eroglu;Pigment Cell Melanoma Res,2019

3. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study;Long;Lancet Oncol,2018

4. Primary analysis and 4-year follow-up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases;Di Giacomo;Clin Cancer Res,2021

5. Immunotherapy for brain metastases and primary brain tumors;Di Giacomo;Eur J Cancer,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery;Journal of Neuro-Oncology;2024-02-03

2. Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities;Journal of Hematology & Oncology;2023-12-16